[Diagnostic value of tissue Doppler parameters in the early diagnosis of cardiomyopathies]

Frank A Flachskampf1, Ole A Breithardt, Werner G Daniel

  • 1Medizinische Klinik 2 (Kardiologie/Angiologie), Universitätsklinikum Erlangen, Ulmenweg 18, 91054, Erlangen, Germany. frank.flachskampf@rzmail.uni-erlangen.de

Herz
|April 3, 2007
PubMed

Insights

Tissue Doppler imaging reveals reduced strain and strain rate in early cardiomyopathy stages. This technique aids in detecting disease carriers and subclinical cardiomyopathy before conventional signs appear.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Echocardiography

Background:

  • Cardiomyopathy encompasses diverse heart muscle diseases.
  • Early detection of cardiomyopathy is crucial for timely intervention.
  • Conventional echocardiography may miss subclinical disease stages.

Purpose of the Study:

  • To evaluate the utility of Tissue Doppler imaging (TDI) and its derived parameters (strain, strain rate) in identifying early and subclinical cardiomyopathy.
  • To assess the detectability of TDI changes in asymptomatic, genetically affected individuals.

Main Methods:

  • Utilized Tissue Doppler imaging to measure longitudinal systolic (S) and early diastolic (E') peak tissue velocities.
  • Assessed strain and strain rate in basal left ventricular segments and right ventricular free wall.
  • Compared findings in patients with dilated, hypertrophic, restrictive cardiomyopathies, and arrhythmogenic right ventricular dysplasia against normal ranges.

Main Results:

  • Reduced S and E' peak tissue velocities were observed in basal left ventricular segments across various cardiomyopathies.
  • Lower strain and strain rate values were found in patients compared to normal controls.
  • These characteristic changes were detectable in asymptomatic and early-stage cardiomyopathy patients, preceding conventional echo signs.

Conclusions:

  • Tissue Doppler analysis demonstrates potential for early identification of cardiomyopathy carriers and subclinical disease.
  • TDI parameters like strain and strain rate offer sensitive markers for early myocardial dysfunction.
  • Standardization issues and limited patient cohorts currently hinder widespread clinical adoption of TDI for cardiomyopathy assessment.

Related Concept Videos

Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...